ReviewInternational journal of molecular sciences2020

c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer's Diseases.

Stephanie Cristine Hepp Rehfeldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.